Use of phthalates as excipients in human medicinal products

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberEMA/CHMP/SWP/362974/2012 Corr. 2
Published24/11/2014
Effective from01/06/2015
KeywordsExcipients, phthalates, endocrine disruptors, dibutyl phthalate (DBP), diethyl phthalate (DEP), cellulose acetate phthalate (CAP), polyvinyl acetate phthalate (PVAP), hydroxypropylmethylcellulose phthalate (HPMCP)
DescriptionThis document aims to review the safety of phthalates most commonly used as excipients in the European Union.


Document history

Revision 1 

Current version

Adopted guideline

 

Overview of comments

 

Draft guideline

In operation: 01/06/2015–present

 

Published: 06/10/2015

 

Published: 08/05/2013


Related content


 

How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more